Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons

被引:61
|
作者
Santiago, MP [1 ]
Potter, LT [1 ]
机构
[1] Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA
关键词
rat; M4 muscarinic receptor; biotinylated m4-toxin; striatonigral projection neuron; striatopallidal projection neuron; retrograde tracing;
D O I
10.1016/S0006-8993(00)03170-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The striatum has nearly equal numbers of striatonigral and striatopallidal projection neurons. All are GABAergic and inhibitory, but they lie in separate neuronal circuits ('direct' and 'indirect', respectively) that appear to exert opposite effects on movement. Methods are needed to evaluate the function of each circuit. A potential way to control striatonigral neurons selectively is via M4 muscarinic receptors. The: striatum has many more M4 receptors than other tissues, they are located on approximately half of all projection neurons, and mRNA for M4 receptors is prevalent only in striatonigral neurons. In order to more rigorously compare the distribution of M4 receptors on rat neurons in these pathways a toxin that binds with very high specificity to M4 receptors (m4-toxin) was biotinylated for use as a selective probe for M4 receptor protein. Pooled biotin-toxin complexes were found to retain high M4-specificity and affinity. Neurons were first labeled by retrograde transport of fluorescent microbeads (FluoSpheres) injected into the substantia nigra and globus pallidus. Coincident labeling of only 4% of the cells confirmed the validity of the retrograde labeling technique. Labeled neurons were probed for M4 receptor protein using biotinylated m4-toxin and fluorescent avidin. M4 receptors were found on 14% of indirect and 86% of direct neurons. It may be concluded that there is a relative abundance of M4 receptors controlling the direct pathway. This work supports the hypothesis that M4-selective drugs will prove useful to control the function of striatonigral neurons in the direct projection pathway. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 50 条
  • [31] PD 102807, a novel muscarinic M4 receptor antagonist, discriminates between striatal and cortical muscarinic receptors coupled to cyclic AMP
    Olianas, MC
    Onali, P
    LIFE SCIENCES, 1999, 65 (21) : 2233 - 2240
  • [32] GUANYLPIRENZEPINE DISTINGUISHES BETWEEN NEURONAL M1 AND M4 MUSCARINIC RECEPTOR SUBTYPES
    MONFERINI, E
    CEREDA, E
    LADINSKY, H
    DONETTI, A
    GIRALDO, E
    JOURNAL OF RECEPTOR RESEARCH, 1990, 10 (1-2): : 81 - 96
  • [33] Cholinergic muscarinic M1/M4 receptor networks in dementia with Lewy bodies
    Colloby, Sean J.
    Nathan, Pradeep J.
    McKeith, Ian G.
    Bakker, Geor
    O'Brien, John T.
    Taylor, John-Paul
    BRAIN COMMUNICATIONS, 2020, 2 (02)
  • [34] Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice
    Gomeza, J
    Zhang, L
    Kostenis, E
    Felder, CC
    Bymaster, FP
    Brodkin, J
    Shannon, H
    Xia, B
    Duttaroy, A
    Deng, CX
    Wess, J
    LIFE SCIENCES, 2001, 68 (22-23) : 2457 - 2466
  • [35] Selectivity of Agonists for the Active State of M1 to M4 Muscarinic Receptor Subtypes
    Figueroa, Katherine W.
    Griffin, Michael T.
    Ehlert, Frederick J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (01): : 331 - 342
  • [36] STEREOSELECTIVITY OF PROCYCLIDINE BINDING TO MUSCARINIC RECEPTOR SUBTYPES M1, M2 AND M4
    WAELBROECK, M
    CAMUS, J
    TASTENOY, M
    LAMBRECHT, G
    MUTSCHLER, E
    TACKE, R
    CHRISTOPHE, J
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 189 (2-3): : 135 - 142
  • [37] Identification, expression and functional characterization of M4L, a muscarinic acetylcholine M4 receptor splice variant
    Schober, Douglas A.
    Croy, Carrie H.
    Ruble, Cara L.
    Tao, Ran
    Felder, Christian C.
    PLOS ONE, 2017, 12 (12):
  • [38] Receptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane
    Bogatkewitsch, GS
    Lenz, W
    Jakobs, KH
    vanKoppen, CJ
    MOLECULAR PHARMACOLOGY, 1996, 50 (02) : 424 - 429
  • [39] M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
    Shen, Weixing
    Plotkin, Joshua L.
    Francardo, Veronica
    Ko, Wai Kin D.
    Xie, Zhong
    Li, Qin
    Fieblinger, Tim
    Wess, Juergen
    Neubig, Richard R.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    Greengard, Paul
    Bezard, Erwan
    Cenci, M. Angela
    Surmeier, D. James
    NEURON, 2015, 88 (04) : 762 - 773
  • [40] Role of M1 and M4 receptors in development of myopia:: Study with muscarinic receptor antagonists and muscarinic toxins
    Diether, S
    Schaeffel, F
    Fritsch, C
    Trendelenburg, AU
    Payor, R
    Lambrou, GN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46